Edematous Fibrosclerotic Panniculopathy
📧 Sign up to get email alerts when something new happens for Edematous Fibrosclerotic Panniculopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks [Phase 2]
Phase 2 trial update reporting results for interventions to reduce bruising after cellulite treatment with CCH-aaes (QWO) in the buttocks.
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite) [Phase 3]
Phase 3 long-term study of EN3835 (CCH-aaes) in edematous fibrosclerotic panniculopathy (cellulite) completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite [Phase 4]
A Phase 4 clinical trial evaluating mitigation treatments for bruising associated with CCH-aaes treatment for buttock cellulite has complete…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques [Phase 2]
Phase 2 clinical trial evaluating two injection techniques for cellulite treatment in the presence of dermal laxity; study completed with po…
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Real World CCH Study in Adult Females With Cellulite [Phase 3]
Phase 3 real-world trial update for adult females with cellulite related to Edematous Fibrosclerotic Panniculopathy (EFP) completed; results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women [Phase 2]
Phase 2 trial update on CCH treatment for cellulite in adult women; study terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) [Phase 2]
Phase 2 clinical trial update for EN3835 in the treatment of edematous fibrosclerotic panniculopathy (cellulite) has completed with results …
-
CLINICAL_TRIALS trial_result · 2020-11-23Clinical Trial Update: Safety and Effectiveness of EN3835 in the Treatment of EFP in Women [Phase 2]
Phase 2 trial update on EN3835 for Edematous Fibrosclerotic Panniculopathy and cellulite shows completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women [Phase 3]
Phase 3 trial evaluating EN3835 for cellulite (Edematous Fibrosclerotic Panniculopathy) in women has completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP [Phase 1]
Phase 1 study reporting safety and pharmacokinetics of a single 3.36 mg dose of CCH in subjects with Edematous Fibrosclerotic Panniculopathy…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) [Phase 2]
Phase 2 trial EN3835 for edematous fibrosclerotic panniculopathy (cellulite) completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy [Phase 2]
Phase 2 randomized, double-blind, placebo-controlled dose ranging study of repeat doses of AA4500 for edematous fibrosclerotic panniculopath…
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) [Phase 1]
Phase 1 study evaluating safety, effectiveness, and pharmacokinetics of AA4500 for edematous fibrosclerotic panniculopathy (cellulite) has c…